MINAPHARM PHARMACEUTICALS SAE EGX:MIPH:
MINAPHARM PHARMACEUTICALS Q3 CONSOL NET PROFIT ATTRIBUTABLE EGP 16.8 MILLION
MINAPHARM PHARMACEUTICALS Q3 CONSOL REVENUE EGP 1.50 BILLION
Minapharm Pharmaceuticals Q3 Consol Profit EGP 16.8 Million
Minapharm Pharmaceuticals on 6ix
Later from Minapharm Pharmaceuticals
- Minapharm Pharmaceuticals FY Standalone Net Profit EGP 57.5 Million
- Minapharm Pharmaceuticals (MIPH.CA) Reports 6 Months Consolidated Results
- Minapharm Pharmaceuticals (MIPH.CA) - Company's Response to the Auditor's Report
Follow Minapharm Pharmaceuticals into a list and get an email when it puts out news.
Follow Minapharm Pharmaceuticals